Navigation Links
Blacks in Poor Areas Less Likely to Be On Kidney Transplant Lists
Date:11/10/2007

Distance to care not a factor, study finds, urging greater outreach to bridge racial gap

SATURDAY, Nov. 10 (HealthDay News) -- Living farther away from transplant centers doesn't explain why black Americans with end-stage renal (kidney) disease are less apt than whites to be placed on the kidney transplant waiting list, researchers say.

A team that analyzed data on end-stage renal (kidney) disease patients in Georgia and the Carolinas from 1998 to 2002 found that black patients in poorer neighborhoods were 56 percent less likely to than whites to be placed on the transplant waiting list.

"This finding warrants further exploration but suggests that racial disparity in the wait-listing process may indeed be a reflection of differential access to health care," study co-author Dr. Sandra Amaral, of Emory University in Atlanta, said in a prepared statement.

Of the almost 12,600 patients (62 percent of them black) included in the study, 17 percent were placed on the kidney transplant waiting list during the study period. Black patients were more likely than whites (27 percent versus 9 percent) to live in areas where more than 25 percent of the population lived below the poverty line.

The researchers had hypothesized that patients who lived farther from transplant centers would be less likely to be placed on the kidney transplant waiting list. But they found that distance to the transplant center didn't have a major impact on the likelihood of being placed on the list. They did find that black patients living in poorer neighborhoods were 56 percent less likely than whites to make it on the list.

"Racial disparities persist in the U.S. transplantation process," Amaral said. "The reasons for this are poorly understood, but multiple factors are likely involved."

"To our knowledge, this is the first study to examine the impact of community poverty on racial disparity in transplant wait-listing. It also
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Older blacks and Latinos still lag whites in controlling diabetes
2. Older Blacks, Latinos Struggle With Diabetes Control
3. Do Blacks Have Genetic Weakness to Asthma?
4. Whites take supplemental breast cancer therapy more often than blacks
5. Prostate cancer more likely to return in blacks than whites, but the disease is not more aggressive
6. Poorer Blood Pressure Control in Blacks With Heart Failure
7. Researchers uncover novel mechanism that balances the sizes of functional areas in the brain
8. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
9. Southern California Wildfires Continue to Threaten Residential Areas
10. DaVita Emergency Response Efforts Ensure Vital Treatment for More than 700 Kidney Failure Patients in Need of Life-Saving Dialysis Treatments in Areas Affected by Southern California Wildfires
11. Announcing Always Best Care Senior Services Expansion Into the Granada Hills/Sherman Oaks, California Areas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...RNewswire-FirstCall/ -- Volcano Corporation,(Nasda...ring and sales of,products for the diagnosis and t..., today announced the relocation of its corporate ...dova to San Diego. The new corporate,headquarters ...and now,houses corporate executives, marketing, fi...
(Date:10/6/2008)...itary personnel and their family members can take,...ssments, BOSTON, Oct. 6 /PRNewswire-USNewswire/ -...members and their families that are unique and,dif... instances matters get,worse and one problem can t... is wise to check things out to see what is really...
(Date:10/6/2008)...t. 6 /PRNewswire/ -- Today, PARI Pharma GmbH will,...ology that uses single,dose ampoules to control me... a proprietary, unit-dose ampoule that is required... eFlow Technology meets an unmet need by,reducing ...very device,simplifying filling procedures, impro...
(Date:10/6/2008)...two Phase 3 studies presented at the American Coll...(ACG) in Orlando, Fla., demonstrated that TAK-390M...le among patients with more severe grades of erosi...azole with a Dual Delayed Release (DDR) formulatio...ug for extended duration of acid suppression. , ...
Breaking Medicine News(10 mins):Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 2Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 3Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 4Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 2Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 3Health News:PARI Pharma Unveils Closed System Using eFlow Technology at Medical Plastics Conference 2Health News:Takeda's investigational PPI TAK-390MR demonstrated higher healing rates compared to lansoprazole 2
... found that radiant-light therapy may be an effect.... Dan Oren, an associate professor of psychiatry a...hat the availability of an easy-to-use, potentiall...py in pregnancy is a clinically attractive option....
...he University of Michigan, have found a gene which... cancer. Using a technique called DNA microarray a...y of thousands of different genes in tissue sample...CoA racemase (AMACR) and it's never before been se...
...ew study, fibrin, a protein that helps form blood ...ir of nerve damage. The discovery could lead to ne... system, such as multiple sclerosis, although the...e level.// In multiple sclerosis, the slow destruc...
...at standing under a tree affords complete protecti...sity. When the sun comes out, it's pleasant to sit...protecting you from the sun. But don't take the sh...urdue University in the US.// They've built a mat...
Other Medicine News:Health News:Clotting Protein plays a role in nerve repair 2
(Date:10/6/2008)... "A return to the use of,chimpanzees in AIDS resea...justification," according to a paper released toda...s (ATLA). "An Assessment of the Role of,Chimpanzee... responses in,chimpanzees are not predictive of re... critical role and importance in AIDS vaccine deve...
(Date:10/6/2008)...to Improve Patient Safety, WASHINGTON, Oct. 6 /PR...rdiology in collaboration with the American Colleg...iation today released consensus guidelines,outlini...cers and,gastrointestinal (GI) bleeding among pati...SAIDs) along with antiplatelet agents., Gastroint...
(Date:10/6/2008)...-FirstCall/ -- Genaera,Corporation (Nasdaq: GENR ...ical trial of trodusquemine (MSI-1436), Genaera,s ...abetes and obesity. MSI-1436 is a novel,inhibitor ...ls the function,of both the leptin and insulin pat...In the study, MSI-1436 was found to be well-tolera...
(Date:10/6/2008)... Naltrexone SR Associated with Bett...t. 6 /- Orexigen Therapeuti...pany focused on the treatment of,obesity and other...resented,data showing the investigational drug, Co...ully achieved key objectives (lowered naltrexone,C...
Breaking Medicine Technology:Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Genes May Play Role in Quitting Smoking 20998 1Genes May Play Role in Quitting Smoking 20998 2Genes May Play Role in Quitting Smoking 20998 3Milestone Scientific Expands Global Distribution Network 20994 1Milestone Scientific Expands Global Distribution Network 20994 2Milestone Scientific Expands Global Distribution Network 20994 3Michael J Fox Foundation for Parkinsons Research Commits up to 242 million to Visualize Alpha Synuclein Protein in the Brain 20990 1Michael J Fox Foundation for Parkinsons Research Commits up to 242 million to Visualize Alpha Synuclein Protein in the Brain 20990 2Michael J Fox Foundation for Parkinsons Research Commits up to 242 million to Visualize Alpha Synuclein Protein in the Brain 20990 3VH1 to Televise The 46664 Concert Honouring Nelson Mandela at 90 Exclusively in the U S 20986 1VH1 to Televise The 46664 Concert Honouring Nelson Mandela at 90 Exclusively in the U S 20986 2VH1 to Televise The 46664 Concert Honouring Nelson Mandela at 90 Exclusively in the U S 20986 3VH1 to Televise The 46664 Concert Honouring Nelson Mandela at 90 Exclusively in the U S 20986 4
...A, Calif.--(BUSINESS WIRE)--Apr 3, 2007 - Calando,...any and a,majority-owned subsidiary of Arrowhead R...blication of a study demonstrating,the anti-prolif...he,therapeutic component of its lead anti-cancer c...RNA Inhibitors of Ribonucleotide,Reductase Subunit...
...ime Reduced By an Average of More Than Two Hours P...07 /PRNewswire/ --,Adding the once daily, investig...4-Hour(TM) Extended-Release Tablets to,Parkinson,s...ificantly reduced ,off, time, allowing patients to...od of time. ,Off time,describes the return of Par...
Other Medicine Technology:Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect,with Lead RNAi Candidate 2Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect,with Lead RNAi Candidate 3Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect,with Lead RNAi Candidate 4Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 2Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 3Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 4Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 5
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 5 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 5 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm.
Medicine Products: